Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1
- Resource Type
- Article
- Source
- In
ESMO Open August 2021 6(4) - Subject
- Language
- ISSN
- 2059-7029